We are live on
!
Find out more
DHFB
Dixon Hubard Feinour & Brown Portfolio holdings
AUM
$842M
1-Year Est. Return
2.74%
This Fund
S&P 500
This Quarter
Est. Return
+8.86%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
–
AUM
$481M
AUM Growth
-$331M
(-41%)
Cap. Flow
-$439M
Cap. Flow
% of AUM
-91.24%
Top 10 Holdings %
Top 10 Hldgs %
33.95%
Holding
227
New
22
Increased
10
Reduced
145
Closed
42
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$8.17M |
| 2 |
Trimble
TRMB
|
+$7.43M |
| 3 |
NVIDIA
NVDA
|
+$7.09M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$6.37M |
| 5 |
iShares MBS ETF
MBB
|
+$6.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$32.7M |
| 2 |
Microsoft
MSFT
|
+$25.9M |
| 3 |
lululemon athletica
LULU
|
+$19.8M |
| 4 |
Veeva Systems
VEEV
|
+$17.6M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$14.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.74% |
| 2 | Healthcare | 19.11% |
| 3 | Consumer Discretionary | 9.45% |
| 4 | Financials | 7.79% |
| 5 | Consumer Staples | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMJ
126
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $452K | 0.09% |
+23,000
| New | +$428K |
|
|
127
lululemon athletica
LULU
$14.6B
| $440K | 0.09% |
1,205
-60,051
| -98% | -$19.8M |
|
128
Atlassian
TEAM
$37.8B
| $438K | 0.09% |
1,705
-2,385
| -58% | -$558K |
|
129
Healthpeak Properties
DOC
$14.8B
| $436K | 0.09% |
13,087
-30,773
| -70% | -$1.03M |
|
130
Mercado Libre
MELI
$92.3B
| $407K | 0.08% |
261
-489
| -65% | -$718K |
|
131
Carrier Global
CARR
$52.8B
| $406K | 0.08% |
8,358
-13,782
| -62% | -$616K |
|
132
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.3B
| $401K | 0.08% |
+4,220
| New | +$397K |
|
133
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
| $390K | 0.08% |
+6,440
| New | +$386K |
|
134
Boeing
BA
$185B
| $384K | 0.08% |
1,602
-1,574
| -50% | -$381K |
|
|
135
Veeva Systems
VEEV
$37.4B
| $381K | 0.08% |
1,225
-63,162
| -98% | -$17.6M |
|
136
Dover
DOV
$28.4B
| $375K | 0.08% |
2,493
-2,493
| -50% | -$368K |
|
137
iShares Core S&P Small-Cap ETF
IJR
$112B
| $374K | 0.08% |
3,314
-4,847
| -59% | -$541K |
|
138
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
| $368K | 0.08% |
+4,093
| New | +$366K |
|
139
ConocoPhillips
COP
$141B
| $366K | 0.08% |
6,007
-7,678
| -56% | -$428K |
|
140
Altria Group
MO
$114B
| $348K | 0.07% |
7,306
-9,271
| -56% | -$456K |
|
141
Nordson
NDSN
$17.3B
| $344K | 0.07% |
1,565
-1,965
| -56% | -$417K |
|
142
Otis Worldwide
OTIS
$28.2B
| $342K | 0.07% |
4,177
-6,889
| -62% | -$530K |
|
143
Nike
NKE
$61.9B
| $341K | 0.07% |
2,209
-2,241
| -50% | -$302K |
|
144
Applied Materials
AMAT
$428B
| $329K | 0.07% |
2,310
| – | – |
|
145
Blackstone
BX
$110B
| $326K | 0.07% |
3,360
| – | – |
|
146
Dow Inc
DOW
$21.2B
| $322K | 0.07% |
5,088
-7,531
| -60% | -$497K |
|
147
Colgate-Palmolive
CL
$74.4B
| $316K | 0.07% |
3,889
-2,501
| -39% | -$204K |
|
148
AstraZeneca
AZN
$250B
| $315K | 0.07% |
2,632
-4,386
| -62% | -$481K |
|
149
Salesforce
CRM
$158B
| $310K | 0.06% |
1,269
-767
| -38% | -$177K |
|
150
United Bankshares
UBSI
$6.62B
| $308K | 0.06% |
8,451
| – | – |
|
Similar funds
BDWM
MCM
TFM
MWM
CP
BWM
FPS
IC
Dixon Hubard Feinour & Brown's Q2 2021 Portfolio in Review
As of Q2 2021, Dixon Hubard Feinour & Brown held 227 positions worth $481M, down 41% from $812M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Dixon Hubard Feinour & Brown withdrew a net $439M in Q2 2021, closing 42 positions and reducing 145 holdings. Its most notable exit was Netflix, an estimated $14.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Dixon Hubard Feinour & Brown opened a new position in CVS Health worth $8.32M.
- Dixon Hubard Feinour & Brown's largest Q2 2021 buy was CVS Health: 99,762 shares worth $8.32M.
- Dixon Hubard Feinour & Brown added most to NVIDIA in Q2 2021, an estimated $7.09M increase.
- Dixon Hubard Feinour & Brown's biggest Q2 2021 reduction was Apple, cutting an estimated $32.7M.
- Dixon Hubard Feinour & Brown fully exited Netflix in Q2 2021, selling an estimated $14.9M.
- Dixon Hubard Feinour & Brown's ten largest holdings make up 34% of its $481M portfolio in Q2 2021.
- Dixon Hubard Feinour & Brown opened 22 new positions and closed 42 in Q2 2021.
- Dixon Hubard Feinour & Brown's portfolio value fell 41% quarter-over-quarter to $481M.
Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2021, filed 23 Aug 2021.